We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GD icon
476
General Dynamics
GD
$106B
$562K 0.03%
2,464
+142
+6% +$32.8K
OII icon
477
Oceaneering
OII
$4.79B
$556K 0.03%
31,550
+6,518
+26% +$126K
GDS icon
478
GDS Holdings
GDS
$6.03B
$553K 0.03%
29,657
+18,549
+167% +$393K
RVNC
479
DELISTED
Revance Therapeutics, Inc.
RVNC
$548K 0.03%
+17,021
New +$531K
MSCI icon
480
MSCI
MSCI
$42.6B
$545K 0.03%
974
+61
+7% +$32.3K
INBX
481
DELISTED
Inhibrx, Inc. Common Stock
INBX
$543K 0.03%
+28,799
New +$670K
EMR icon
482
Emerson Electric
EMR
$84.9B
$532K 0.03%
6,102
-475
-7% -$41.5K
CHRS icon
483
Coherus Oncology
CHRS
$222M
$527K 0.03%
+77,101
New +$598K
CNC icon
484
Centene
CNC
$31B
$524K 0.03%
8,287
-1,469
-15% -$104K
AXON
485
Axon Enterprise
AXON
$43.8B
$522K 0.03%
2,321
-170
-7% -$33.8K
WELL icon
486
Welltower
WELL
$172B
$522K 0.03%
7,279
-2,244
-24% -$163K
DHI icon
487
D.R. Horton
DHI
$42.4B
$521K 0.03%
5,334
+1,862
+54% +$178K
MTD icon
488
Mettler-Toledo International
MTD
$27.9B
$519K 0.03%
339
-2,285
-87% -$3.43M
RYAAY icon
489
Ryanair
RYAAY
$30.6B
$518K 0.03%
13,738
+1,048
+8% +$38.7K
RS icon
490
Reliance Steel & Aluminium
RS
$21.1B
$517K 0.03%
2,014
-1,205
-37% -$284K
NI icon
491
NiSource
NI
$22.1B
$516K 0.03%
18,449
-1,040
-5% -$28.5K
NSC icon
492
Norfolk Southern
NSC
$77.2B
$515K 0.03%
2,431
-148
-6% -$34.2K
FHN icon
493
First Horizon
FHN
$12.2B
$514K 0.03%
28,927
+4,013
+16% +$89.2K
VICI icon
494
VICI Properties
VICI
$29.9B
$514K 0.03%
15,766
-2,804
-15% -$92.8K
BTAI icon
495
BioXcel Therapeutics
BTAI
$25.9M
$512K 0.03%
+1,716
New +$733K
APTV icon
496
Aptiv
APTV
$12.4B
$511K 0.03%
4,554
+1,345
+42% +$148K
SYY icon
497
Sysco
SYY
$40.9B
$510K 0.03%
6,599
-1,491
-18% -$114K
KROS icon
498
Keros Therapeutics
KROS
$198M
$506K 0.03%
+11,844
New +$598K
FLNA
499
Filana Therapeutics
FLNA
$43.7M
$506K 0.03%
+20,963
New +$581K
STLD icon
500
Steel Dynamics
STLD
$37.4B
$505K 0.03%
4,471
-123
-3% -$14.3K
18 19
20
21 22

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.